Skip to content

Sunday, December 22, 2024

Latest:

Understanding the cascade of molecular events leading to Rett syndrome
The need for language inclusivity in clinical research
Caring for your feet with a diabetes diagnosis
Mapping functional relations among proteins and genes helps illuminate their role in cancer
Occupational therapy: what patients need to know

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

androgen-targeting therapy

From The Labs

A new mechanism to explain benign prostatic hyperplasia

October 14, 2016 androgen-targeting therapy, bening prostatic hyperplasia, Il-1, inflammation, prostate

Benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate, affects about half the men between 51 and 60 years of age, and nine out

From the Labs: Image of the Month

From the Labs: Humans are complex genetic mosaics.